FDA Approves Amarin Drug Vascepa
July 26, 2012 at 18:09 PM EDT
Amarin (AMRN) said shortly before 6 p.m. on Thursday that the FDA has approved its drug Vascepa for the treatment people with high levels of triglycerides. “FDA approval of Vascepa represents the introduction of an important new treatment option for patients with severe hypertriglyceridemia,” the company said. Analysts have estimated the drug could have sales [...]
